StemCell Institute (TSE:7096) Gross-Profit-to-Asset % : 0.00% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is StemCell Institute Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. StemCell Institute's annualized Gross Profit for the quarter that ended in Sep. 2024 was 円0 Mil. StemCell Institute's average Total Assets over the quarter that ended in Sep. 2024 was 円6,739 Mil. Therefore, StemCell Institute's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 was 0.00%.

StemCell Institute Gross-Profit-to-Asset % Historical Data

The historical data trend for StemCell Institute's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StemCell Institute Gross-Profit-to-Asset % Chart

StemCell Institute Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

35.52

24.57

24.23

25.51

StemCell Institute Quarterly Data
	Mar18	Mar19	Dec19	Mar20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial													25.40	27.23	27.82	22.50	-

Competitive Comparison of StemCell Institute's Gross-Profit-to-Asset %

For the Biotechnology subindustry, StemCell Institute's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

StemCell Institute's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, StemCell Institute's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where StemCell Institute's Gross-Profit-to-Asset % falls into.

Save Embed

;

Save Embed

;

StemCell Institute Gross-Profit-to-Asset % Calculation

StemCell Institute's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Mar. 2024 )	/	( (Total Assets (A: Mar. 2023 )	+	Total Assets (A: Mar. 2024 ))	/ count )
	=	1575.882	/	( (5811.615	+	6543.075)	/ 2 )
	=	1575.882	/	6177.345
	=	25.51 %

StemCell Institute's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Sep. 2024 )	/	( (Total Assets (Q: Mar. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
	=	0	/	( (6543.075	+	6935.288)	/ 2 )
	=	0	/	6739.1815
	=	0.00 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

StemCell Institute Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of StemCell Institute's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

StemCell Institute Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemCell Institute (TSE:7096) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Shimbashi, Minato-ku, Tamuracho Building, Matsuoka, Tokyo, JPN, 105-0004

Website

https://www.stemcell.co.jp

StemCell Institute is engaged in Cell bank business that separates and stores cord blood for regenerative medicine. Cord blood is the baby's blood contained in the umbilical cord and placenta that connects mother and baby. In its umbilical cord blood storage business, upon receiving notification from customers who have contracted, umbilical cord blood collected at obstetric facilities throughout Japan is collected, transported to the company's own cell processing center within 48 hours, and it provides a service to store cells at ultra-low temperature after separating cells from blood.

StemCell Institute Headlines

No Headlines